Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity

Journal of Biological Chemistry

Volumn 288, Issue 18, 2013, Pages 12615-12626

  Kabuta, Tomohiro ^a   Mitsui, Takeshi ^a,b   Takahashi, Masaki ^a   Fujiwara, Yuuki ^a,b   Kabuta, Chihana ^a   Konya, Chiho ^a   Tsuchiya, Yukihiro ^a   Hatanaka, Yusuke ^a   Uchida, Kenko ^b   Hohjoh, Hirohiko ^a   Wada, Keiji ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN-DEPENDENT KINASE; HUMAN CANCER CELLS; HYDROLASE ACTIVITIES; INTERACTION LEVELS; KINASE ACTIVITY; MOLECULAR FUNCTION; MULTIPLE CELL TYPES; RNA INTERFERENCE;

CELL PROLIFERATION; CELLS; CYTOLOGY; DISEASES; INTERFERENCE SUPPRESSION; RNA; TISSUE;

HYDROLASES;

CYCLIN DEPENDENT KINASE; HYDROLASE; RNA; UBIQUITIN THIOLESTERASE;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL TYPE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SEQUENCE HOMOLOGY; XENOGRAFT;

CANCER; CELL GROWTH; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE (CDK); PROTEIN COMPLEXES; PROTEIN-PROTEIN INTERACTIONS; TUMOR MARKER; UCH-L1;

ANIMALS; CDC2 PROTEIN KINASE; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 5; HELA CELLS; HUMANS; MICE; MUTATION; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS; NIH 3T3 CELLS; TRANSPLANTATION, HETEROLOGOUS; UBIQUITIN THIOLESTERASE;

MUS;

EID: 84877103246     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.435701     Document Type: Article

References (57)

1. Morgan, D. O. (1997) Cyclin-dependent kinases. Engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291
2. Lew, J., Huang, Q. Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., and Wang, J. H. (1994) A brain-specific activator of cyclin-dependent kinase 5. Nature 371, 423-426 (Pubitemid 24302557)
3. Nikolic, M., Dudek, H., Kwon, Y. T., Ramos, Y. F., and Tsai, L. H. (1996) The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816-825 (Pubitemid 26114738)
4. Hartwell, L. H., and Kastan, M. B. (1994) Cell cycle control and cancer. Science 266, 1821-1828
5. Yang, Y., Mufson, E. J., and Herrup, K. (2003) Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J. Neurosci. 23, 2557-2563 (Pubitemid 36418589)
6. Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A. L., Degregori, J., Oertel, W. H., Rakic, P., Hirsch, E. C., and Hunot, S. (2007) The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 104, 3585-3590 (Pubitemid 46364202)
7. Wilkinson, K. D., Lee, K. M., Deshpande, S., Duerksen-Hughes, P., Boss, J. M., and Pohl, J. (1989) The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246, 670-673 (Pubitemid 19283361)
8. Kwon, J., Wang, Y. L., Setsuie, R., Sekiguchi, S., Sakurai, M., Sato, Y., Lee, W. W., Ishii, Y., Kyuwa, S., Noda, M., Wada, K., and Yoshikawa, Y. (2004) Developmental regulation of ubiquitin C-terminal hydrolase isozyme expression during spermatogenesis in mice. Biol. Reprod. 71, 515-521 (Pubitemid 38970527)
9. Sekiguchi, S., Kwon, J., Yoshida, E., Hamasaki, H., Ichinose, S., Hideshima, M., Kuraoka, M., Takahashi, A., Ishii, Y., Kyuwa, S., Wada, K., and Yoshikawa, Y. (2006) Localization of ubiquitin C-terminal hydrolase L1 in mouse ova and its function in the plasma membrane to block polyspermy. Am. J. Pathol. 169, 1722-1729 (Pubitemid 351182003)
10. Howell, V. M., Gill, A., Clarkson, A., Nelson, A. E., Dunne, R., Delbridge, L. W., Robinson, B. G., Teh, B. T., Gimm, O., and Marsh, D. J. (2009) Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J. Clin. Endocrinol. Metab. 94, 434-441
11. Tezel, E., Hibi, K., Nagasaka, T., and Nakao, A. (2000) PGP9.5 as a prognostic factor in pancreatic cancer. Clin. Cancer Res. 6, 4764-4767 (Pubitemid 32110417)
12. Yamazaki, T., Hibi, K., Takase, T., Tezel, E., Nakayama, H., Kasai, Y., Ito, K., Akiyama, S., Nagasaka, T., and Nakao, A. (2002) PGP9.5 as a marker for invasive colorectal cancer. Clin. Cancer Res. 8, 192-195 (Pubitemid 34101477)
13. Hibi, K., Westra, W. H., Borges, M., Goodman, S., Sidransky, D., and Jen, J. (1999) PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am. J. Pathol. 155, 711-715 (Pubitemid 29426816)
14. Miyoshi, Y., Nakayama, S., Torikoshi, Y., Tanaka, S., Ishihara, H., Taguchi, T., Tamaki, Y., and Noguchi, S. (2006) High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci. 97, 523-529 (Pubitemid 43811594)
15. Takase, T., Hibi, K., Yamazaki, T., Nakayama, H., Taguchi, M., Kasai, Y., Ito, K., Akiyama, S., Nagasaka, T., and Nakao, A. (2003) PGP9.5 overexpression in esophageal squamous cell carcinoma. Hepatogastroenterology 50, 1278-1280 (Pubitemid 37186464)
16. Otsuki, T., Yata, K., Takata-Tomokuni, A., Hyodoh, F., Miura, Y., Sakaguchi, H., Hatayama, T., Hatada, S., Tsujioka, T., Sato, Y., Murakami, H., Sadahira, Y., and Sugihara, T. (2004) Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells. Br. J. Haematol. 127, 292-298 (Pubitemid 39468942)
17. Giambanco, I., Bianchi, R., Ceccarelli, P., Pula, G., Sorci, G., Antonioli, S., Bocchini, V., and Donato, R. (1991) "Neuron-specific" protein gene product 9.5 (PGP 9.5) is also expressed in glioma cell lines and its expression depends on cellular growth state. FEBS Lett. 290, 131-134
18. Ovaa, H., Kessler, B. M., Rolén, U., Galardy, P. J., Ploegh, H. L., and Masucci, M. G. (2004) Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. Proc. Natl. Acad. Sci. U.S.A. 101, 2253-2258 (Pubitemid 38269298)
19. Al-Katib, A. M., Mohammad, R. M., Maki, A., and Smith, M. R. (1995) Induced expression of a ubiquitin COOH-terminal hydrolase in acute lymphoblastic leukemia. Cell Growth & Differ. 6, 211-217
20. Hussain, S., Foreman, O., Perkins, S. L., Witzig, T. E., Miles, R. R., van Deursen, J., and Galardy, P. J. (2010) The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling. Leukemia 24, 1641-1655
21. Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., Dehejia, A., Lavedan, C., Gasser, T., Steinbach, P. J., Wilkinson, K. D., and Polymeropoulos, M. H. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395, 451-452
22. Setsuie, R., Wang, Y. L., Mochizuki, H., Osaka, H., Hayakawa, H., Ichihara, N., Li, H., Furuta, A., Sano, Y., Sun, Y. J., Kwon, J., Kabuta, T., Yoshimi, K., Aoki, S., Mizuno, Y., Noda, M., and Wada, K. (2007) Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant. Neurochem. Int. 50, 119-129 (Pubitemid 44879668)
23. Bilguvar, K., Tyagi, N. K., Ozkara, C., Tuysuz, B., Bakircioglu, M., Choi, M., Delil, S., Caglayan, A. O., Baranoski, J. F., Erturk, O., Yalcinkaya, C., Karacorlu, M., Dincer, A., Johnson, M. H., Mane, S., Chandra, S. S., Louvi, A., Boggon, T. J., Lifton, R. P., Horwich, A. L., and Gunel, M. (2013) Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 110, 3489-3494
24. Larsen, C. N., Krantz, B. A., and Wilkinson, K. D. (1998) Substrate specificity of deubiquitinating enzymes. Ubiquitin C-terminal hydrolases. Biochemistry 37, 3358-3368 (Pubitemid 28125563)
25. Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., and Lansbury, P. T., Jr. (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111, 209-218 (Pubitemid 35292441)
26. Osaka, H., Wang, Y. L., Takada, K., Takizawa, S., Setsuie, R., Li, H., Sato, Y., Nishikawa, K., Sun, Y. J., Sakurai, M., Harada, T., Hara, Y., Kimura, I., Chiba, S., Namikawa, K., Kiyama, H., Noda, M., Aoki, S., and Wada, K. (2003) Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet. 12, 1945-1958 (Pubitemid 37038804)
27. Kabuta, T., Setsuie, R., Mitsui, T., Kinugawa, A., Sakurai, M., Aoki, S., Uchida, K., and Wada, K. (2008) Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. Hum. Mol. Genet. 17, 1482-1496 (Pubitemid 351627344)
28. Kabuta, T., Furuta, A., Aoki, S., Furuta, K., and Wada, K. (2008) Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J. Biol. Chem. 283, 23731-23738
29. Kabuta, T., and Wada, K. (2008) Insights into links between familial and sporadic Parkinson's disease. Physical relationship between UCH-L1 variants and chaperone-mediated autophagy. Autophagy 4, 827-829
30. Malakhova, O. A., Kim, K. I., Luo, J. K., Zou, W., Kumar, K. G., Fuchs, S. Y., Shuai, K., and Zhang, D. E. (2006) UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25, 2358-2367 (Pubitemid 44012219)
31. Kabuta, T., Suzuki, Y., and Wada, K. (2006) Degradation of amyotrophic lateral sclerosis-linked mutant Cu,Zn-superoxide dismutase proteins by macroautophagy and the proteasome. J. Biol. Chem. 281, 30524-30533 (Pubitemid 44582109)
32. Kabuta, T., Kinugawa, A., Tsuchiya, Y., Kabuta, C., Setsuie, R., Tateno, M., Araki, T., and Wada, K. (2009) Familial amyotrophic lateral sclerosis-linked mutant SOD1 aberrantly interacts with tubulin. Biochem. Biophys. Res. Commun. 387, 121-126
33. Higashi, S., Tsuchiya, Y., Araki, T., Wada, K., and Kabuta, T. (2010) TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase. Neurochem. Int. 57, 906-913
34. Higashi, S., Iseki, E., Minegishi, M., Togo, T., Kabuta, T., and Wada, K. (2010) GIGYF2 is present in endosomal compartments in the mammalian brains and enhances IGF-1-induced ERK1/2 activation. J. Neurochem. 115, 423-437
35. Kabuta, T., Hakuno, F., Asano, T., and Takahashi, S. (2002) Insulin receptor substrate-3 functions as transcriptional activator in the nucleus. J. Biol. Chem. 277, 6846-6851 (Pubitemid 34953067)
36. Fujiwara, Y., Furuta, A., Kikuchi, H., Aizawa, S., Hatanaka, Y., Konya, C., Uchida, K., Yoshimura, A., Tamai, Y., Wada, K., and Kabuta, T. (2013) Discovery of a novel type of autophagy targeting RNA. Autophagy 9, 403-409
37. Kabuta, T., Take, K., Kabuta, C., Hakuno, F., and Takahashi, S. (2008) Differential subcellular localization of insulin receptor substrates depends on C-terminal regions and importin beta. Biochem. Biophys. Res. Commun. 377, 741-746
38. Kabuta, T., Hakuno, F., Cho, Y., Yamanaka, D., Chida, K., Asano, T., Wada, K., and Takahashi, S. (2010) Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-κB activity. Biochem. Biophys. Res. Commun. 394, 697-702
39. Kawauchi, T., Chihama, K., Nabeshima, Y., and Hoshino, M. (2006) Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat. Cell Biol. 8, 17-26 (Pubitemid 43064793)
40. Smith, P. D., Crocker, S. J., Jackson-Lewis, V., Jordan-Sciutto, K. L., Hayley, S., Mount, M. P., O'Hare, M. J., Callaghan, S., Slack, R. S., Przedborski, S., Anisman, H., and Park, D. S. (2003) Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 13650-13655 (Pubitemid 37444794)
41. Nishikawa, K., Li, H., Kawamura, R., Osaka, H., Wang, Y. L., Hara, Y., Hirokawa, T., Manago, Y., Amano, T., Noda, M., Aoki, S., and Wada, K. (2003) Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Biochem. Biophys. Res. Commun. 304, 176-183 (Pubitemid 36434213)
42. Jeffrey, P. D., Russo, A. A., Polyak, K., Gibbs, E., Hurwitz, J., Massagué, J., and Pavletich, N. P. (1995) Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376, 313-320
43. Mann, D. A., Trowern, A. R., Lavender, F. L., Whittaker, P. A., and Thompson, R. J. (1996) Identification of evolutionary conserved regulatory sequences in the 5′ untranscribed region of the neural-specific ubiquitin C-terminal hydrolase (PGP9.5) gene. J. Neurochem. 66, 35-46
44. Kaminosono, S., Saito, T., Oyama, F., Ohshima, T., Asada, A., Nagai, Y., Nukina, N., and Hisanaga, S. (2008) Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability. J. Neurosci. 28, 8747-8755
45. Morgan, D. O. (1995) Principles of CDK regulation. Nature 374, 131-134
46. Kwon, J., Kikuchi, T., Setsuie, R., Ishii, Y., Kyuwa, S., and Yoshikawa, Y. (2003) Characterization of the testis in congenitally ubiquitin carboxy-terminal hydrolase-1 (Uch-L1) defective (gad) mice. Exp. Anim. 52, 1-9 (Pubitemid 41349985)
47. Santamaría, D., Barrière, C., Cerqueira, A., Hunt, S., Tardy, C., Newton, K., Cáceres, J. F., Dubus, P., Malumbres, M., and Barbacid, M. (2007) Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448, 811-815 (Pubitemid 47266342)
48. Rane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., and Barbacid, M. (1999) Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nat. Genet. 22, 44-52
49. Caballero, O. L., Resto, V., Patturajan, M., Meerzaman, D., Guo, M. Z., Engles, J., Yochem, R., Ratovitski, E., Sidransky, D., and Jen, J. (2002) Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). Oncogene 21, 3003-3010 (Pubitemid 34522899)
50. Kim, H. J., Kim, Y. M., Lim, S., Nam, Y. K., Jeong, J., Kim, H. J., and Lee, K. J. (2009) Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene 28, 117-127
51. Okochi-Takada, E., Nakazawa, K., Wakabayashi, M., Mori, A., Ichimura, S., Yasugi, T., and Ushijima, T. (2006) Silencing of the UCHL1 gene in human colorectal and ovarian cancers. Int. J. Cancer 119, 1338-1344 (Pubitemid 44258809)
52. Kagara, I., Enokida, H., Kawakami, K., Matsuda, R., Toki, K., Nishimura, H., Chiyomaru, T., Tatarano, S., Itesako, T., Kawamoto, K., Nishiyama, K., Seki, N., and Nakagawa, M. (2008) CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma. J. Urol. 180, 343-351
53. Hoozemans, J. J., Brückner, M. K., Rozemuller, A. J., Veerhuis, R., Eikelenboom, P., and Arendt, T. (2002) Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J. Neuropathol. Exp. Neurol. 61, 678-688 (Pubitemid 34851771)
54. McShea, A., Harris, P. L., Webster, K. R., Wahl, A. F., and Smith, M. A. (1997) Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am. J. Pathol. 150, 1933-1939 (Pubitemid 27233067)
55. Busser, J., Geldmacher, D. S., and Herrup, K. (1998) Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J. Neurosci. 18, 2801-2807 (Pubitemid 28163210)
56. Nagy, Z., Esiri, M. M., and Smith, A. D. (1997) Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol. 93, 294-300 (Pubitemid 27104426)
57. Arendt, T., Rödel, L., Gärtner, U., and Holzer, M. (1996) Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport. 7, 3047-3049 (Pubitemid 26426387)